Abstract
Despite significant advancements in Total Knee Arthroplasty (TKA) and the increased quality of life they provide, more than one in five patients are left dissatisfied with the outcomes of their surgery. This is not a new phenomenon, and with 1.37 million TKA’s performed in the US and Australia last year alone, new solutions are needed to address this issue.
Recent research highlights a link between the sensorimotor system and function following TKA. Mounting evidence highlights that sensory alterations that occur through surgery have a large impact on recovery, and that persistent functional limitations may be due to sensorimotor issues. This presentation will outline a new project aimed to improve outcomes for TKA patients. The project, initiated by NeuMo Tech Pty Ltd, will involve the first randomised controlled trial of
their Neuromodulation Technology. Neuromodulation Technology is a neuromuscular exercise program that is non-invasive, patient-driven, and can be used in the home. Pilot studies have found Neuromodulation Technology to be influential to muscle activation in TKA patients during gait. The trial will compare Neuromodulation Technology to the current standard of post-surgery care during the early stages of recovery. To align with solving patient dissatisfaction, and to truly capture what matters to patients, the initial stages of the project will consist of TKA patient interviews. These interviews will help define the endpoints used in the trial. Endpoints will also be discussed with clinicians and industry partners, ensuring all stakeholders are considered in defining what makes a successful TKA recovery.
The talk will cover the methodology of the project and its potential impact, whilst also highlighting the value of the new Flinders University Enterprise PhD Scholarship scheme, through which the project will be completed.
Recent research highlights a link between the sensorimotor system and function following TKA. Mounting evidence highlights that sensory alterations that occur through surgery have a large impact on recovery, and that persistent functional limitations may be due to sensorimotor issues. This presentation will outline a new project aimed to improve outcomes for TKA patients. The project, initiated by NeuMo Tech Pty Ltd, will involve the first randomised controlled trial of
their Neuromodulation Technology. Neuromodulation Technology is a neuromuscular exercise program that is non-invasive, patient-driven, and can be used in the home. Pilot studies have found Neuromodulation Technology to be influential to muscle activation in TKA patients during gait. The trial will compare Neuromodulation Technology to the current standard of post-surgery care during the early stages of recovery. To align with solving patient dissatisfaction, and to truly capture what matters to patients, the initial stages of the project will consist of TKA patient interviews. These interviews will help define the endpoints used in the trial. Endpoints will also be discussed with clinicians and industry partners, ensuring all stakeholders are considered in defining what makes a successful TKA recovery.
The talk will cover the methodology of the project and its potential impact, whilst also highlighting the value of the new Flinders University Enterprise PhD Scholarship scheme, through which the project will be completed.
| Original language | English |
|---|---|
| Publication status | Published - 1 Oct 2025 |
| Event | IUPESM World Congress on Medical Physics and Biomedical Engineering 2025 - Adelaide Convention Centre, Adelaide, Australia Duration: 29 Sept 2025 → 4 Oct 2025 https://wc2025.org/ |
Conference
| Conference | IUPESM World Congress on Medical Physics and Biomedical Engineering 2025 |
|---|---|
| Abbreviated title | IUPESM 2025 |
| Country/Territory | Australia |
| City | Adelaide |
| Period | 29/09/25 → 4/10/25 |
| Internet address |